MENU
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Context Therapeutics (CNTX) Ownership - Who owns Context Therapeutics?
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more
Profile
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
56.46M
P/E Ratio
N/A
Total Cash
89.35M
Projected Growth
N/A
Total Debt
193.71K
Revenue
N/A
Risk (Beta)
1.95
Dividend Yield
N/A
Total Cash/Share
1.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CNTX
Capitalization
56.5M
P/E Ratio
N/A
Risk (Beta)
1.95
Dividend Yield
N/A
Total Cash
89.4M
Total Cash/Share
1.00
Total Debt
194K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
91M
P/B Ratio
0.62
Cash Flow
N/A
Earnings
-0.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
89.7K
Current Ratio
48.80
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-31.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-53.13
Shares Held By Institutions
58M
Shares Outstanding - Current
89.7M
Total Liabilities
1.98M
Total Volume MTD
N/A
Value
1
Gain YTD
-40.057
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com